Evidence map›Paper›PMID 42187048›Full record

ArticleJournal of chemical information and modeling2026

Alanine Rewires the Communication Pathways Established During the Allosteric Activation of Liver Pyruvate Kinase by Fructose Bisphosphate.

Jacques Kumutima, Xin-Qiu Yao, Donald Hamelberg

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jacques KumutimaDepartment of Chemistry, Georgia State University, Atlanta, Georgia30302-3965, United States.
Xin-Qiu YaoDepartment of Chemistry, University of Nebraska Omaha, Omaha, Nebraska68182, United States.ORCID 0000-0003-2706-2028
Donald HamelbergDepartment of Chemistry, Georgia State University, Atlanta, Georgia30302-3965, United States.ORCID 0000-0002-3785-3037

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allostery enables enzymes to transmit information from distant ligand-binding sites to catalytic centers through residue-to-residue communication pathways. Human liver pyruvate kinase (hL-PYK) is a prototypical system that integrates activating input from fructose-1,6-bisphosphate (FBP) and inhibitory input from alanine, yet how these opposing signals propagate through the protein remains unclear. Here, we combine multimicrosecond molecular dynamics of the hL-PYK tetramer with residue-residue contact analysis and network/path mapping to define the underlying communication pathways. Contact-change correlations show that alanine antagonizes FBP by reversing many FBP-induced rearrangements. Difference contact network analysis and path enumeration reveal that FBP and alanine rewire information flow along partially overlapping but distinct routes between the allosteric and active sites; residues with high path degeneracy, acting as hubs, emerge as key conduits and include positions that overlap with prior mutational hotspots while also suggesting new sites for experimental testing. Residue community analysis further demonstrates intercommunity edges that switch sign or weaken upon alanine binding, indicating inhibition via residue-residue contact network rerouting. Together, these results support a mechanistic model in which alanine rewires the communication pathways established during FBP-mediated activation of hL-PYK and provide concrete hypotheses for modulating enzyme activity with allosteric therapeutics.

Indexed as

AlanineFructosediphosphatesLiverPyruvate KinaseAllosteric RegulationCatalytic DomainEnzyme ActivationHumansMolecular Dynamics SimulationAlaninefructose-1,6-diphosphateFructosediphosphatesPyruvate Kinase

Identifiers

PMID42187048
PMCPMC13250992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.